United States · FDA National Drug Code directory
tizanidine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8776_62f55001-6aa3-4baa-b6d2-564c09dab4ed
- Product NDC
- 68788-8776
- Form
- CAPSULE
- Composition / generic term
- tizanidine hydrochloride
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241209
- Source listing expiry
- 20271231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (68788-8776-1) · 68788-8776-1
- 20 CAPSULE in 1 BOTTLE (68788-8776-2) · 68788-8776-2
- 30 CAPSULE in 1 BOTTLE (68788-8776-3) · 68788-8776-3
- 60 CAPSULE in 1 BOTTLE (68788-8776-6) · 68788-8776-6
- 120 CAPSULE in 1 BOTTLE (68788-8776-8) · 68788-8776-8
- 90 CAPSULE in 1 BOTTLE (68788-8776-9) · 68788-8776-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →